Mirum Pharmaceuticals Inc (MIRM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.98B
Last updated: Nov 17, 2026 at 4:10 PM ET
Mirum Pharmaceuticals Inc (MIRM) Stock Chart
Mirum Pharmaceuticals (MIRM) has a latest price of $91.95 on Nov 17, 2026, 29.3% below its 52-week high of $130.00. Its price rose 28.7% over the past 12 months. The month-end price rose 435.3% over the 5 years through Oct 2026, a compound annual rate of 39.9%.
Price Chart
From Jul 2019 to Oct 2026, its highest month-end close was $117.07 in Jun 2026 and its lowest $7.18 in Oct 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MIRM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MIRM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 10.1%, and over 6 months it fell 3.9%. The month-end price rose 209.9% over the 3 years through Oct 2026, a compound annual rate of 45.8%.
| Period | Change |
|---|---|
| 1 month | +11.8% |
| 3 months | -10.1% |
| 6 months | -3.9% |
| 12 months | +28.7% |
| 12 months, with dividends | +28.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +209.9% | +45.8% |
| 5 years | +435.3% | +39.9% |
Price by Year
Its best calendar year was 2025, when the price rose 91.0%, and its weakest was 2020, when it fell 28.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $85.00 | +7.6% |
| 2025 | $78.99 | +91.0% |
| 2024 | $41.35 | +40.1% |
| 2023 | $29.52 | +51.4% |
| 2022 | $19.50 | +22.3% |
| 2021 | $15.95 | -8.6% |
| 2020 | $17.46 | -28.8% |
Trading Range
The price is 4.0% above its 50-day average of $88.45 and 6.5% below its 200-day average of $98.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $91.95 | |
| 52-week high | $130.00 | -29.3% |
| 52-week low | $63.23 | +45.4% |
| 50-day average | $88.45 | +4.0% |
| 200-day average | $98.29 | -6.5% |
Price Risk
Over 3 years, its largest fall from a peak was 38.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.08 |
| Largest fall, 1 year | -38.4% |
| Largest fall, 3 years | -38.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MIRM
What is MIRM's 1-year price change?
Mirum Pharmaceuticals's price rose 28.7% over the past 12 months. With dividends included, the 12-month total return was 28.7%.
What is MIRM's 5-year price change?
Mirum Pharmaceuticals's month-end price rose 435.3% over the 5 years through Oct 2026, a compound annual rate of 39.9%. These figures leave out dividends.
What is MIRM's 52-week high and low?
Mirum Pharmaceuticals's 52-week high is $130.00 and its 52-week low is $63.23. Its latest price of $91.95 on Nov 17, 2026 is 29.3% below the high.
What is MIRM's beta?
Mirum Pharmaceuticals's 1-year beta against the S&P 500 is 1.08, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 38.4%.
Is the MIRM chart free?
Yes. Advanced Charting for MIRM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MIRM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors, Government Contracts